Details for 2016723107
Up to date per 01.04.2026
Actions
Details for 2016723107
Granted/Registered
European Patent
28.03.2018 A
04.09.2019 B1
18.05.2015
US
201562162870 P
A61K 31/5383 20060101AFI20190426BHEP
Owner
KaNDy Therapeutics Limited400 South Oak Way Reading, Berkshire, RG2 6ADGB
Representative
Representative
Dipl.-Ing. Dr. Gerda RedlDonau-City-Straße 111200 WienAT
Inventor
TROWER, Mikec/o NeRRe Therapeutics Limited Stevenage Bioscience Cat. Incub. Bldg. Gunnels Wood Road Stevenage Hertfordshire SG1 2FXGB
Information about Fees